Introduction
============

Despite an increasing cancer incidence in both genders, the effects of sex on colorectal cancer, lung cancer and gastric cancer incidence are well established and women are less likely to develop cancers than men [@B1], [@B2]. In Taiwan, lung (ranked 1^st^), colorectal (ranked 3^rd^) and gastric (ranked 6^th^) cancers were the top 10 of most common cause of cancer death in 2011 [@B3]. Variable environmental exposures, life styles and comorbidities may contribute to these findings.

Comparisons of International Agency for Research on Cancer / World Health Organization (IARC/WHO) data showed that there were associations between incidences of lung and colon cancers in men [@B4], [@B5]. The incidences of cancers in colon and lung are higher in patients with diabetes [@B6]. Long-term use of statins was associated with increased risk colorectal and lung cancers [@B7]. The hormone replacement therapy also has been reported to be associated with reduced incidence of lung and colorectal cancer [@B8], [@B9]. In addition, the epidermal growth factor receptors (EGFR) are involved in the pathogenesis and prognostic significance of solid tumors such as cancers of the lung, colon, stomach, bladder, breast, and ovary [@B10], [@B11].The cancers of different body sites seem to correlate with one another. Finally, we examined our data to determine the cancer associations with sex disparities.

Materials and Methods
=====================

Study Population
----------------

We compared data through the National Cancer Registration Program in Taiwan and IARC/WHO from 1995 to 1998. The data for Taiwan were obtained directly from Office of Statistics, Department of Health in Taiwan. Since incidence rates for the under 30-year age group are often low, and rates for the over 80-year group might be affected by competitive death effects and incomplete data, only rates for the age range 30 to 79 were enrolled to ensure adequate reliability of the estimates. The involved 19 countries were Australia, Canada, Denmark, England, Estonia, France, Iceland, India, Israel, Italy, Japan, The Netherlands, Poland, Singapore, Slovakia, Spain, Switzerland, United States and Taiwan. We compared age-standardized incidence rates (ASIR) among Taiwan and countries of WHO members. The significance of cross-township and cross-country correlations for gastric cancer, colon cancer and lung adenocarcinoma were evaluated for both sexes.

Statistical Analysis
--------------------

ASIR were calculated by using world population for 1976 as the reference [@B12]. The significance of correlations among tumor types for cross-township and cross-country comparisons was evaluated with the SAS ver. 9.2 software package (SAS Institute, Cary, NC, USA). Correlation coefficients were generated by Pearson correlation coefficients, with *p*\<0.05 considered to be significant.

Results
=======

The ASIR from gastric cancer, colorectal cancer and lung adenocarcinoma per 100000 person-year in 19 countries from 1995 to 1998 are presented in Table [1](#T1){ref-type="table"}. The highest incident rates were people in Japan for gastric cancer, men in Slovakia and women in Australia for colorectal cancer, and people in United States for lung adenocarcinoma. The range of male-female sex ratio among countries was 1.8 in India to 2.8 in France for gastric cancer, 1.1 in India to 1.9 in Slovkia for colorectal cancer, and 1.0 in Iceland to 4.7 in Spain for lung adenocarcinoma. These ratios remained relatively constant for gastric and colon cancer, but there were high varieties in sex ratio for lung adenocarcinoma.

Cross-country comparisons of cancers between men and women are present in Table [2a](#T2a){ref-type="table"}. Significant correlations in colorectal cancer, gastric cancer and lung adenocarcinoma were observed between men and women, with Pearson\'s correlation 0.918 (p\<0.001), 0.985 (p\<0.001) and 0.685 (p=0.001), respectively. There was a positive correlation between lung adenocarcinoma in men and colorectal cancer in women (r=0.571, p=0.011). The results for pairs of cancers in 19 countries are listed for men in Table [2b](#T2b){ref-type="table"} and for women in Table [2c](#T2c){ref-type="table"}. There was a significant correlation between colorectal cancer and lung adenocarcinoma in men (r=0.526, p=0.021), but not in women (r=0.278, p=0.250).

Cross-township comparisons of cancers between Taiwanese men and women are showed in Table [3a](#T3a){ref-type="table"}. There were significant correlations in colorectal cancer (r= 0.451, p\<0.001), gastric cancer (r=0.486, p\<0.001) and lung adenocarcinoma (r=0.217, p\<0.001) between men and women. Significances between male colorectal cancer and female lung adenocarcinoma (r=0.280, p\<0.001), and male lung adenocarcinoma and female colorectal cancer (r=0.258, p\<0.001) were also observed. The results for significance of correlation coefficients for pairs of cancers in Taiwan are presented for men in Table [3b](#T3b){ref-type="table"} and for women in Table [3c](#T3c){ref-type="table"}. There were links of lung adenocarcinoma and gastric cancer (r=0.122, p=0.024) and colorectal cancer (r=0.128, p=0.018) in women, and lung adenocarcinoma and colorectal cancer (r=0.276, p\<0.001) in men. There was a trend between cancers of stomach and colorectum in men, but it did not reach significance (r=0.101, p=0.062).

Discussion
==========

We found that the sex ratio in cancers varied geographically. The incidences of gastric and colorectal cancer throughout different populations show male dominance with a constant male-to-female ratio. This sex ratio cannot be completely attributed to the disparities in the prevalence of known risk factors between the sexes [@B13], [@B14]. Recent advances in the molecular biology of gastric and colorectal cancer have led to greater understanding of the effect of estrogen in carcinogenesis. Estrogen has a potentially protective effect against the development of colorectal cancer [@B15] and invasions of gastric cancer [@B16], and may be the cause of improved prognosis of colorectal cancer in premenopausal women [@B17]. Also, women on hormone replacement therapy seem to have a decreased risk of gastric and colorectal cancer [@B18]. However, use of tamoxifen, an antagonist of the estrogen receptor, in women seems to increase their risk of gastric cancer [@B19].

Moore et al. conducted cross-country comparisons for cancer incidence in men [@B4], [@B5] and concluded that some factors could be involved in the association between lung adenocarcinoma and colorectal cancer. Cigarette smoke contains many carcinogens, and the gastrointestinal tracts are exposed to these compounds through the circulation or direct ingestion of saliva [@B20]. The relationships between smoking and increased risks of gastric and colorectal cancer have been established [@B21], [@B22]. However, few studies examining the effects of passive smoke exposure on risk of gastric cancer report inconsistent results [@B23], [@B24]. Passive smoke exposure on risk of colorectal cancer shows no association among women [@B25]. In Taiwan, lung adenocarcinoma and colorectal cancer were correlated in both sexes and between sexes, but not in the cross-country comparisons. Most of the female lung cancer patients in Taiwan were non-smokers and the proportion was more than 90% [@B8]. The relationship with passive smoking and smoking might be limited and incompatible with the observed association between lung adenocarcinoma and colorectal cancer so that other factors must be operating.

Obesity and overweight have become a global problem in the last decade. Given its documented promoting effects on colon carcinogenesis, insulin resistance and hyperinsulinaemia are certainly key biological mechanisms involving in tumor development [@B26]. The data from Taiwan National Health Insurance showed that the incidences of the most common cancers, such as liver, colon, lung, and prostate cancer increased independently in diabetic patients with hypertension, dyslipidemia, and gout [@B6]. Use of insulin was also reported to be associated with higher risks for liver, colorectal, lung, stomach, and pancreas cancer in type 2 diabetes in Taiwan [@B27]. The use of anti-diabetes drugs also has been reported to decrease the risk of lung cancer in diabetes patients [@B28]. Insulin resistance might play a role in the association between lung adenocarcinoma and colorectal cancer in Taiwanese, but it was not consistent with cross-country comparisons.

In Taiwan, the incidence of lung cancer is increasing and lung adenocarcinoma is the most common histological subtypes of lung cancer [@B29]. Among lung cancer patients without traditional risk factors, a substantial proportion of patients are found to have oncogene-driven malignancies, such as EGFR. It has been reported that mutations in genes encoding EGFR pathway proteins result in multiple aberrations in the signal-transduction pathways and dysregulation of the tyrosine kinase activity, and lead to tumor cell proliferation, inhibition of apoptosis, and dissemination [@B30]. More than 60% of non-small-cell lung cancers show EGFR overexpression [@B31], which is negatively prognostic [@B32]. The frequency of tumor EGFR mutations was found to be higher in East Asian ethnicity, such as Taiwan [@B33], [@B34].

Luo et al. found that multiple primary malignancies occurred more frequently in patients with lung adenocarcinoma and classic EGFR mutation [@B35]. Amplification and overexpression of EGFR also have been involved in development of numerous types of human cancer [@B36]. EGFR is widely expressed in colonic tissues and EGFR genes have gender-specific prognostic significance in colon cancer [@B37]. Wang et al. reported that low EGFR expression in patients with colorectal cancer was associated with low tumor metastasis and better survival [@B38]. Besides, amplification or overexpression of EGFR is present in gastric carcinomas with independent prognostic value [@B39], [@B40]. EGFR mutations and overexpression have been intensely pursued as extremely valuable for treatment of lung adenocarcinoma patients in Asian countries including Taiwan, where the EGFR mutation rate is higher than in the rest of the world.

One of the strengths of our study was the use of registered database, which was population-based and highly representative. A number of important limitations warrant discussion. First, we did not obtain basic information on smoking rate, air pollution, physical inactivity, incidence of diabetes, and dietary habits and rate of Helicobacter pylori infection. Second, as a result of modernization and life style changes globally, the incidence of the studied countries may have changed. The results from data collected between 1995 and 1998 could be established as a reference or model to which future studies could compare.

Conclusions
===========

International and cross-township comparisons of tumor incidences can provide information on risk factors shared by different tissue sites. The main finding of our study is that link between lung adenocarcinoma and colorectal cancers may be associated with the increased risk in adenocarcinoma. To find shared candidate genes will lead to an understanding of the genetic associations and sex disparities among cancers, the development of more effective treatments, and better guiding future risk-stratification efforts , especially Taiwanese susceptible to adenocarcinoma.
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###### 

Age standardized incidence rate in the age range 30 to 79 (per 100000 person year) from stomach and colorectal cancer, and lung adenocarcinoma in 19 countries, 1995-1998.

  Country         Colorectal cancer   Gastric cancer   Lung adenocarcinoma                                      
  --------------- ------------------- ---------------- --------------------- ------- ------ ----- ------ ------ -----
  Australia       98.0                65.5             1.5                   19.4    8.3    2.3   21.9   10.8   2.0
  Canada          81.5                55.0             1.5                   16.9    7.2    2.3   29.9   23.9   1.3
  Denmark         74.4                58.6             1.3                   15.2    6.9    2.2   28.2   25.1   1.1
  England         77.1                48.4             1.6                   28.0    10.9   2.6   16.7   11.2   1.5
  Estonia         65.9                42.2             1.6                   68.3    29.8   2.3   10.6   3.2    3.3
  France          85.7                49.6             1.7                   22.0    8.0    2.8   30.7   7.0    4.4
  Iceland         57.4                40.1             1.4                   24.1    9.8    2.5   22.9   23.7   1.0
  India           11.4                9.8              1.1                   17.7    9.6    1.8   4.2    2.0    2.1
  Israel          75.1                61.4             1.2                   23.0    12.4   1.9   14.8   8.3    1.8
  Italy           85.9                55.1             1.6                   45.2    22.7   2.0   34.4   8.4    4.1
  Japan           90.7                50.3             1.8                   123.5   47.8   2.6   27.5   14.1   2.0
  Netherlands     90.3                60.8             1.5                   29.3    10.8   2.7   26.3   9.1    2.9
  Poland          58.6                38.4             1.5                   33.1    13.0   2.5   12.3   4.4    2.8
  Singapore       85.9                60.0             1.4                   46.0    22.8   2.0   34.0   18.7   1.8
  Slovakia        101.3               52.3             1.9                   42.3    17.2   2.5   16.0   4.1    3.9
  Spain           64.7                43.1             1.5                   28.6    11.6   2.5   17.5   3.7    4.7
  Switzerland     66.0                41.2             1.6                   19.1    9.3    2.1   26.1   14.5   1.8
  United States   77.1                54.8             1.4                   14.8    6.3    2.3   39.5   29.4   1.3
  Taiwan          23.5                19.2             1.2                   15.1    8.0    1.9   19.2   15.5   1.2

###### 

Cross 19 country correlations of cancers between men and women.

  Site and tumor type      Female              
  --------------------- -- --------- --------- --------
  Colorectum                                   
  r                        0.918     0.263     0.110
  *p*                      \<0.001   0.276     0.651
  Stomach                                      
  r                        0.107     0.985     -0.202
  *p*                      0.662     \<0.001   0.406
  Lung adenocarcinoma                          
  r                        0.571     0.010     0.685
  *p*                      0.011     0.966     0.001

###### 

Cross 19 country correlations between cancers in men.

  Site and tumor type   Colorectum   Stomach   Lung adenocarcinoma
  --------------------- ------------ --------- ---------------------
  Colorectum                                   
  r                     1            0.301     0.526
  *p*                                0.209     0.021
  Stomach                                      
  r                                  1         0.012
  *p*                                          0.960
  Lung adenocarcinoma                          
  r                                            1
  *p*                                          

###### 

Cross 19 country correlations between cancers in women.

  Site and tumor type   Colorectum   Stomach   Lung adenocarcinoma
  --------------------- ------------ --------- ---------------------
  Colorectum                                   
  r                     1            0.095     0.278
  *p*                                0.700     0.250
  Stomach                                      
  r                                  1         -0.216
  *p*                                          0.374
  Lung adenocarcinoma                          
  r                                            1
  *p*                                          

###### 

Cross 346 township correlations of cancers between male and female Taiwanese.

  Site and tumor type                          Female
  --------------------- -- --------- --------- ---------
  Colorectum                                   
  r                        0.451     -0.035    0.280
  *p*                      \<0.001   0.518     \<0.001
  Stomach                                      
  r                        -0.027    0.486     -0.045
  *p*                      0.616     \<0.001   0.402
  Lung adenocarcinoma                          
  r                        0.258     -0.007    0.217
  *p*                      \<0.001   0.902     \<0.001

###### 

Cross 346 township correlations between cancers in male Taiwanese.

  Site and tumor type   Colorectum   Stomach   Lung adenocarcinoma
  --------------------- ------------ --------- ---------------------
  Colorectum                                   
  r                     1            -0.035    0.276
  *p*                                0.512     \<0.001
  Stomach                                      
  r                                  1         0.101
  *p*                                          0.062
  Lung adenocarcinoma                          
  r                                            1
  *p*                                          

###### 

Cross 346 township correlations between cancers in female Taiwanese.

  Site and tumor type   Colorectum   Stomach   Lung adenocarcinoma
  --------------------- ------------ --------- ---------------------
  Colorectum                                   
  r                     1            0.020     0.128
  *p*                                0.717     0.018
  Stomach                                      
  r                                  1         0.122
  *p*                                          0.024
  Lung adenocarcinoma                          
  r                                            1
  *p*                                          
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